REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 49 filers reported holding REPARE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,091,043 | +14.2% | 2,242,636 | 0.0% | 14.51% | +24.7% |
| Q2 2023 | $23,727,089 | +7.5% | 2,242,636 | 0.0% | 11.64% | +26.5% |
| Q1 2023 | $22,067,538 | -33.1% | 2,242,636 | 0.0% | 9.20% | -33.4% |
| Q4 2022 | $32,989,176 | +21.3% | 2,242,636 | 0.0% | 13.80% | +33.2% |
| Q3 2022 | $27,203,000 | -13.3% | 2,242,636 | 0.0% | 10.36% | -21.7% |
| Q2 2022 | $31,374,000 | -1.8% | 2,242,636 | 0.0% | 13.24% | +21.3% |
| Q1 2022 | $31,935,000 | -32.5% | 2,242,636 | 0.0% | 10.92% | +6.8% |
| Q4 2021 | $47,297,000 | -19.6% | 2,242,636 | 0.0% | 10.22% | -25.1% |
| Q3 2021 | $58,847,000 | -16.9% | 2,242,636 | -1.3% | 13.64% | +3.6% |
| Q2 2021 | $70,815,000 | -11.4% | 2,271,177 | -12.8% | 13.16% | -14.7% |
| Q1 2021 | $79,889,000 | -22.5% | 2,603,089 | -13.3% | 15.43% | +5.9% |
| Q4 2020 | $103,029,000 | +11.5% | 3,003,772 | 0.0% | 14.58% | -15.4% |
| Q3 2020 | $92,426,000 | -0.8% | 3,003,772 | 0.0% | 17.24% | -37.8% |
| Q2 2020 | $93,177,000 | – | 3,003,772 | – | 27.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,560,703 | $78,588,000 | 15.73% |
| MPM ASSET MANAGEMENT LLC | 2,603,089 | $79,889,000 | 15.43% |
| MPM BioImpact LLC | 2,069,749 | $63,521,000 | 7.98% |
| BVF INC/IL | 3,722,398 | $114,240,000 | 4.28% |
| StepStone Group LP | 8,721 | $268,000 | 4.12% |
| Logos Global Management LP | 900,000 | $27,621,000 | 2.70% |
| Redmile Group, LLC | 2,665,496 | $81,804,000 | 1.15% |
| Orbimed Advisors | 3,426,325 | $105,154,000 | 0.98% |
| Soleus Capital Management, L.P. | 133,324 | $4,092,000 | 0.74% |
| SPHERA FUNDS MANAGEMENT LTD. | 248,100 | $7,614,000 | 0.58% |